Novel Systemic Treatments for Brain Metastases From Lung Cancer

Current Treatment Options in Neurology(2018)

引用 6|浏览12
暂无评分
摘要
Purpose of review Brain metastases are frequent complication of lung cancer and are associated with poor prognosis. Patients with brain metastases secondary to lung cancer have traditionally been managed with surgery and radiation with limited role for systemic chemotherapy. In the past decade, however, this paradigm has shifted largely due to the advent of targeted therapies and immunotherapies, both of which have demonstrated efficacy in the treatment of brain metastases and extracranial disease. Recent findings While patients with brain metastases secondary to lung cancer have historically been excluded from trials, recent data suggest efficacy of novel targeted therapies and immunotherapies in these patients. In fact, there are multiple ongoing trials to further evaluate these therapies in this patient profile. Summary Targeted therapies and immunotherapies have the potential to improve outcomes in patients with brain metastases secondary to lung cancer.
更多
查看译文
关键词
Brain metastases,Lung cancer,EGFR,ALK,Targeted therapy,Immunotherapy,Clinical trials
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要